Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

China Pharma Holdings (CPHI) Other Non Operating Income (2016)

China Pharma Holdings' Other Non Operating Income history spans 5 years, with the latest figure at -$3324.0 for Q4 2016.

  • For Q4 2016, Other Non Operating Income rose 78.06% year-over-year to -$3324.0; the TTM value through Dec 2016 reached $327871.0, down 80.01%, while the annual FY2016 figure was $343023.0, 79.09% down from the prior year.
  • Other Non Operating Income reached -$3324.0 in Q4 2016 per CPHI's latest filing, down from -$2325.0 in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $1.7 million in Q3 2015 to a low of -$15152.0 in Q4 2015.
  • Average Other Non Operating Income over 3 years is $292666.7, with a median of $27.0 recorded in 2014.
  • The largest YoY upside for Other Non Operating Income was 2443.84% in 2015 against a maximum downside of 56218.52% in 2015.
  • A 3-year view of Other Non Operating Income shows it stood at $27.0 in 2014, then crashed by 56218.52% to -$15152.0 in 2015, then skyrocketed by 78.06% to -$3324.0 in 2016.
  • Per Business Quant, the three most recent readings for CPHI's Other Non Operating Income are -$3324.0 (Q4 2016), -$2325.0 (Q3 2016), and $348672.0 (Q2 2016).